IE914498A1 - Treatment of cystic fibrosis and pharmaceutical compositions¹for use therein - Google Patents

Treatment of cystic fibrosis and pharmaceutical compositions¹for use therein

Info

Publication number
IE914498A1
IE914498A1 IE449891A IE449891A IE914498A1 IE 914498 A1 IE914498 A1 IE 914498A1 IE 449891 A IE449891 A IE 449891A IE 449891 A IE449891 A IE 449891A IE 914498 A1 IE914498 A1 IE 914498A1
Authority
IE
Ireland
Prior art keywords
pharmaceutically acceptable
utp
composition
acceptable salt
cystic fibrosis
Prior art date
Application number
IE449891A
Other languages
English (en)
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of IE914498A1 publication Critical patent/IE914498A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IE449891A 1990-12-22 1991-12-20 Treatment of cystic fibrosis and pharmaceutical compositions¹for use therein IE914498A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909027968A GB9027968D0 (en) 1990-12-22 1990-12-22 Method of treatment

Publications (1)

Publication Number Publication Date
IE914498A1 true IE914498A1 (en) 1992-07-01

Family

ID=10687552

Family Applications (1)

Application Number Title Priority Date Filing Date
IE449891A IE914498A1 (en) 1990-12-22 1991-12-20 Treatment of cystic fibrosis and pharmaceutical compositions¹for use therein

Country Status (3)

Country Link
GB (1) GB9027968D0 (fr)
IE (1) IE914498A1 (fr)
WO (1) WO1992011016A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0517573A1 (fr) * 1991-06-05 1992-12-09 Synthelabo Compositions pharmaceutiques pour le traitement des affections des voies respiratoires
US5292498A (en) * 1991-06-19 1994-03-08 The University Of North Carolina At Chapel Hill Method of treating lung disease with uridine triphosphates
AU7965694A (en) * 1993-10-15 1995-05-04 Curators Of The University Of Missouri, The Dna encoding the human p2u receptor and null cells expressing p2u receptors
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
EP0766570B1 (fr) * 1995-04-13 2001-12-12 Milkhaus Laboratory, Inc. Procedes de traitement des maladies respiratoires
US5948768A (en) * 1995-04-13 1999-09-07 Milkhaus Laboratory Treatment of otitis media by sublingual administration of DNA
US6096721A (en) * 1995-04-13 2000-08-01 Milkhaus Laboratory, Inc. Method for treating mucositis by sublingual administration of DNA
US5628984A (en) 1995-07-31 1997-05-13 University Of North Carolina At Chapel Hill Method of detecting lung disease
US6423694B1 (en) * 1996-02-21 2002-07-23 Inspire Pharmaceuticals, Inc. Method of treating otitis media with uridine triphosphates and related compounds
US5962432A (en) * 1996-07-03 1999-10-05 Inspire Pharmaceuticals, Inc. Sterilized, isotonic and pH-adjusted pharmaceutical formulation of uridine triphosphate
US5789391A (en) * 1996-07-03 1998-08-04 Inspire Pharmaceuticals, Inc. Method of treating sinusitis with uridine triphosphates and related compounds
US5968913A (en) * 1996-07-03 1999-10-19 Inspire Pharmaceuticals, Inc. Pharmaceutical compositions of uridine triphosphate
US5763447C1 (en) 1996-07-23 2002-05-07 Inspire Pharmaceuticals Method of preventing or treating pneumonia in immobilized patients with uridine triphosphates and related compounds
US6159952A (en) * 1996-11-07 2000-12-12 Inspire Pharmaceuticals, Inc. Method of treating bronchitis with uridine triphosphate and related compounds
US6998121B2 (en) 2003-01-23 2006-02-14 Milkhaus Laboratory, Inc. Method of treatment of connective tissue disorders by administration of streptolysin O
CA2300146A1 (fr) * 1997-08-29 1999-03-04 Richard C. Boucher, Jr. Utilisation d'uridine 5'-diphosphate et d'analogues de ces derniers pour le traitement de maladies pulmonaires
US7629312B2 (en) 2003-01-23 2009-12-08 Milkhaus Laboratory, Inc. Method of treatment of tendonitis by administration of streptolysin O

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5583M (fr) * 1966-06-03 1968-01-08

Also Published As

Publication number Publication date
GB9027968D0 (en) 1991-02-13
WO1992011016A1 (fr) 1992-07-09

Similar Documents

Publication Publication Date Title
US5683675A (en) Method of treating retained pulmonary secretions
IE914498A1 (en) Treatment of cystic fibrosis and pharmaceutical compositions¹for use therein
EP0831777B1 (fr) Dinucleotides utiles dans le traitement de maladies pulmonaires
US5478578A (en) Powders for inhalation
EP0731688B1 (fr) Compositions medicamenteuses en aerosol pour utilisation avec des gaz propulseurs sans cfc
EA013351B1 (ru) Фармацевтические препараты, содержащие бета-агонист длительного действия, для введения путем распыления
CN1170356A (zh) 气溶胶药物制剂
KR20010075637A (ko) 포르모테롤을 함유하는 저장 가능한 활성 물질 농축물
CA2239308A1 (fr) Nouvelle combinaison
CZ20033580A3 (cs) Aerosolový prostředek
US6129905A (en) Aerosol formulations containing a sugar as a dispersant
USRE36744E (en) Nasal administration of benzodiazepine hypnotics
EA018589B1 (ru) Применение композиции, содержащей формотерол и дипропионат беклометазона, для предотвращения и/или лечения обострения астмы
US20020155068A1 (en) Inhalatory compositions of formoterol
EP0365119B1 (fr) Composition pharmaceutique
IE920484A1 (en) Pharmaceutical Formulations
CA2354576C (fr) Preparation pharmaceutique pour inhalation d'un opioide
WO2002028368A1 (fr) Nouveau medicament combine pour le traitement de l"asthme
WO1996022764A1 (fr) Liposomes contenant un corticosteroide
WO2001015777A1 (fr) Administration pulmonaire d'ascorbates mineraux
US2798834A (en) Streptomycin plus dihydrostreptomycin compositions
IE54532B1 (en) Improvements in or relating to nasal pharmaceutical compositions
JPH0141126B2 (fr)
JPH03200727A (ja) 喘息治療剤

Legal Events

Date Code Title Description
FC9A Application refused sect. 31(1)